author-photo

Eric Hedrick

Duke University

4

Papers

186

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Response rate using conventional criteria is a poor surrogate for clinical benefit on progression-free (PFS) and overall survival (OS) in metastatic colorectal cancer (mCRC): A comparative analysis of N9741 and AVF2107

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (151)
Post-progression therapy (PPT) effect on survival in AVF2107, a phase III trial of bevacizumab in first-line treatment of metastatic colorectal cancer (mCRC)

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (30)